STXS CIK: 1289340

Stereotaxis, Inc.

  • United States
  • Healthcare
  • MedTech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
Change from FY21 to FY25
millions USD
FY21:
−2.95
FY22:
−8.42
FY23:
−9.14
FY24:
−8.50
FY25:
−13.7
Change from FY21 to FY25
millions USD
FY21:
−1.40
FY22:
−22.1
FY23:
19.8
FY24:
0.07
FY25:
−0.09
Change from FY21 to FY25
millions USD
FY21:
0.55
FY22:
0.22
FY23:
0.08
FY24:
0.30
FY25:
14.8
millions USD
FY21:
−3.80
FY22:
−30.3
FY23:
10.7
FY24:
−8.13
FY25:
0.99
(positive)
Change from FY21 to FY25
millions USD
FY21:
−4.34
FY22:
−10.8
FY23:
−9.51
FY24:
−8.53
FY25:
−13.8

All amounts in millions USD Data source:SEC EDGAR